We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Intestine microbes that convert sugar into very important short-chain fatty acids level the best way to novel therapeutics
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Intestine microbes that convert sugar into very important short-chain fatty acids level the best way to novel therapeutics
Intestine microbes that convert sugar into very important short-chain fatty acids level the best way to novel therapeutics
Health

Intestine microbes that convert sugar into very important short-chain fatty acids level the best way to novel therapeutics

Last updated: March 3, 2025 10:14 am
Editorial Board Published March 3, 2025
Share
SHARE

A Kobe College staff discovered that glucose is excreted into the small gut, the place micro organism rework it into short-chain fatty acids. Credit score: Kobe College

Intestine microbes that have been thought to feed completely on dietary fiber additionally get fed sugar from our guts, from which they produce short-chain fatty acids which are essential to many physique capabilities. The Kobe College discovery of this symbiotic relationship additionally factors the best way to creating novel therapeutics.

The staff have printed their ends in the journal Communications Medication.

Intestine microbes produce many substances that our physique wants however can’t produce itself. Amongst them are short-chain fatty acids which are the first power supply for the cells lining our guts however produce other vital roles, too, and which are regarded as produced by micro organism who feed on undigested fiber.

Nonetheless, in a earlier research, the Kobe College endocrinologist Ogawa Wataru discovered that individuals who take the diabetes drug metformin excrete the sugar glucose to the within of their guts. He says, “If glucose is indeed excreted into the gut, it is conceivable that this could affect the symbiotic relationship between the gut microbiome and the host.”

Ogawa and his staff got down to be taught extra concerning the particulars of glucose excretion and its relationship with the intestine microbiota. “We had to develop unprecedented bioimaging methods and establish novel analytical techniques for the products of the gut microbial metabolism,” he says.

They used their new strategies to not solely see the place and the way a lot glucose enters the center, but in addition used mouse experiments to learn the way the sugar is reworked after that. As well as, additionally they checked how the diabetes drug metformin influences these outcomes each in people and in mice.

This time lapse footage exhibits that glucose is excreted within the “jejunum,” part of the small gut, and is transported from there contained in the intestine to the big gut and the rectum. Credit score: Morita Yasuko, Communications Medication 2025 (DOI: 10.1038/s43856-025-00755-4)

The staff discovered that, first, glucose is excreted within the “jejunum,” part of the small gut, and is transported from there contained in the intestine to the big gut and the rectum.

“It was surprising to find that even individuals not taking metformin exhibited a certain level of glucose excretion into the intestine. This finding suggests that intestinal glucose excretion is a universal physiological phenomenon in animals, with metformin acting to enhance this process,” Ogawa explains.

In each people and mice, regardless of whether or not they have been diabetic or not, metformin elevated the excretion by an element of virtually 4.

And second, on the best way down, the glucose will get reworked into short-chain fatty acids. Ogawa says, “The production of short-chain fatty acids from the excreted glucose is a huge discovery. While these compounds are traditionally thought to be produced through the fermentation of indigestible dietary fibers by gut microbiota, this newly identified mechanism highlights a novel symbiotic relationship between the host and its microbiota.”

Ogawa and his staff at the moment are conducting additional research with the goal of understanding how metformin and different diabetes medicine have an effect on glucose excretion, the intestine microbiome and their metabolic merchandise.

He says, “Intestinal glucose excretion represents a previously unrecognized physiological phenomenon. Understanding the underlying molecular mechanisms and how drugs interfere with this process could lead to the development of novel therapeutics aimed at the regulation of gut microbiota and their metabolites.”

Extra info:
Metformin-regulated glucose flux from the circulation to the intestinal lumen, Communications Medication (2025). DOI: 10.1038/s43856-025-00755-4

Supplied by
Kobe College

Quotation:
Intestine microbes that convert sugar into very important short-chain fatty acids level the best way to novel therapeutics (2025, March 3)
retrieved 3 March 2025
from https://medicalxpress.com/information/2025-02-gut-microbes-sugar-vital-short.html

This doc is topic to copyright. Aside from any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

You Might Also Like

Research present nurses play a crucial function for individuals with rheumatic musculoskeletal illnesses

US measles depend nears 1,200 instances as Ohio officers affirm 3 outbreaks are over

FDA approves pembrolizumab for resectable head and neck most cancers with PD-L1 expression

Osteoarthritis: Too many non-evidence-based therapies?

The worth of bodily exercise for individuals with RMD

TAGGED:AcidsconvertFattygutmicrobespointshortchainSugarTherapeuticsvital
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
How Georgia Beat Alabama to Win College Football’s National Championship
Sports

How Georgia Beat Alabama to Win College Football’s National Championship

Editorial Board January 11, 2022
Rick Pitino explains benching RJ Luis Jr. in St. John’s NCAA Match loss, confirms draft-hopeful Luis won’t be again
Your Step-by-Step Information to Internet hosting a E book Membership
Trump dodges blame for surprising dip within the economic system
Death Toll During Pandemic Far Exceeds Totals Reported by Countries, W.H.O. Says

You Might Also Like

Coronary heart illness and diabetes drive surge in deaths amongst Individuals with out faculty levels
Health

Coronary heart illness and diabetes drive surge in deaths amongst Individuals with out faculty levels

June 14, 2025
Compound present in rice bran can suppress intestinal contractions by inhibiting calcium inflow
Health

Compound present in rice bran can suppress intestinal contractions by inhibiting calcium inflow

June 14, 2025
Decline in youth bodily health seen in affiliation with pandemic
Health

Decline in youth bodily health seen in affiliation with pandemic

June 14, 2025
Alcohol-linked liver deaths rising in ladies and younger adults, finds research
Health

Alcohol-linked liver deaths rising in ladies and younger adults, finds research

June 14, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?